Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nexalin Technology, Inc. (NXL) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nexalin Technology, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1527352.
Total stock buying since 2022: $242,519.
Total stock sales since 2022: $0.
Total stock option exercises since 2022: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 13,500 | $34,130 | 0 | $0 | 0 | $0 |
| 2024 | 7,119 | $6,849 | 0 | $0 | 0 | $0 |
| 2022 | 55,500 | $201,540 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-03 | 6,000 | $13,200 | 0 | $0 | 0 | $0 |
| 2025-02 | 3,000 | $9,180 | 0 | $0 | 0 | $0 |
| 2025-01 | 4,500 | $11,750 | 0 | $0 | 0 | $0 |
| 2024-10 | 500 | $1,095 | 0 | $0 | 0 | $0 |
| 2024-08 | 1,000 | $950 | 0 | $0 | 0 | $0 |
| 2024-06 | 5,619 | $4,804 | 0 | $0 | 0 | $0 |
| 2022-09 | 55,500 | $201,540 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-12 | Shelton Carolyn Hamby (Sr. VP - Quality, Regulatory) | Buy | 6,000 | 2.20 | 13,200 |
| 2025-02-04 | Owens David (Chief Medical Officer) | Buy | 2,000 | 3.04 | 6,080 |
| 2025-01-28 | Owens David (Chief Medical Officer) | Buy | 1,500 | 2.70 | 4,050 |
| 2025-01-23 | Owens David (Chief Medical Officer) | Buy | 1,000 | 2.70 | 2,700 |
| 2025-01-13 | Owens David (Chief Medical Officer) | Buy | 2,000 | 2.50 | 5,000 |
| 2024-10-28 | Owens David (Chief Medical Officer) | Buy | 500 | 2.19 | 1,095 |
| 2024-08-13 | Owens David (Chief Medical Officer) | Buy | 1,000 | .95 | 950 |
| 2024-06-28 | Owens David (Chief Medical Officer) | Buy | 1,000 | 1.75 | 1,750 |
| 2024-06-18 | Owens David (Chief Medical Officer) | Buy | 1,619 | .71 | 1,149 |
| 2024-06-10 | Owens David (Chief Medical Officer) | Buy | 3,000 | .64 | 1,905 |
| 2022-09-28 | Osser Leonard | Buy | 9,500 | 1.12 | 10,640 |
| 2022-09-16 | Kazden Alan | Buy | 2,500 | 4.15 | 10,375 |
| 2022-09-16 | Owens David (Chief Medical Officer) | Buy | 2,500 | 4.15 | 10,375 |
| 2022-09-16 | White Mark (President/CEO) | Buy | 2,500 | 4.15 | 10,375 |
| 2022-09-16 | Morad Rick | Buy | 2,500 | 4.15 | 10,375 |
| 2022-09-16 | Osser Leonard | Buy | 36,000 | 4.15 | 149,400 |
Insider trading activities including stock purchases, stock sales, and option exercises of NXL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nexalin Technology, Inc. (symbol NXL, CIK number 1527352) see the Securities and Exchange Commission (SEC) website.